All In Biotech

Drug Trial Radar · NCT07571005

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure (AMAZE 3)

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

May 5, 2026

Primary completion

Jul 12, 2028

Study completion Oct 4, 2028

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
May 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated with positive airway pressure lose weight and improve sleep apnoea. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111, (the treatment being tested) or Placebo (a treatment that has no active medicine in it) and which treatment participants get is decided by chance.

Conditions

  • Obesity
  • Overweight
  • Obstructive Sleep Apnoea

Interventions

  • NNC0487-0111Drug

    NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

  • Placebo (matched to NNC0487-0111)Drug

    Placebo matched to NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in body weightTime frame: From baseline (week 0) to (week 80)
  2. Change in apnoea-hypopnoea index (AHI)Time frame: From baseline (week 0) to (week 80)

Locations

80 sites in 10 countries. Site status is shown where the registry gives one.

  • Artemis Insitute for Clin Res

    San Diego, California · Recruiting

  • PharmaDev Clinical Research Institute LLC

    Miami, Florida · Recruiting

  • Essence MD Research

    Naples, Florida · Not yet recruiting

  • Renstar Medical Research

    Ocala, Florida · Recruiting

  • Conquest Research

    Atlanta, Georgia · Recruiting

  • Physicians Research Associates

    Lawrenceville, Georgia · Recruiting

  • University Of Chicago

    Chicago, Illinois · Recruiting

  • Weil Cornell Medicine

    New York, New York · Recruiting

  • CTI Clinical Research Center

    Cincinnati, Ohio · Recruiting

  • Clinical Research Associates of Central PA, LLC

    DuBois, Pennsylvania · Not yet recruiting

  • Epic Medical Research

    DeSoto, Texas · Recruiting

  • Advanced Neurology Epilepsy and Sleep Center ANESC

    El Paso, Texas · Recruiting

  • Biorhythms Center for Integrative Sleep Medicine

    El Paso, Texas · Recruiting

  • Houston Pulm Med Res Network

    Houston, Texas · Recruiting

  • Sleep Therapy Research Center

    San Antonio, Texas · Recruiting

  • Tricoastal Sleep Center

    Sugar Land, Texas · Recruiting

  • Rainier Clin Res Ctr Inc

    Renton, Washington · Recruiting

  • Woolcock Institute

    Macquarie Park, New South Wales, Australia · Recruiting

  • University of Sunshine Coast - Vitality Village

    Birtinya, Queensland, Australia · Recruiting

  • Mater Research - RIO Clinical Trials Unit

    South Brisbane, Queensland, Australia · Not yet recruiting

  • Nightingale Research Adelaide

    Adelaide, South Australia, Australia · Recruiting

  • University of Western Australia - Centre for Sleep Science

    Crawley, Western Australia, Australia · Recruiting

  • Peking University People's Hospital-Endocrinology

    Beijing, Beijing Municipality, China · Recruiting

  • The Second Affiliated Hospital of Nanjing Medical University-Endocrinology

    Nanjing, Jiangsu, China · Recruiting

  • The First Affiliated Hospital of Soochow University-Endocrinology

    Suzhou, Jiangsu, China · Recruiting

  • The Affiliated Hospital of Jiangsu University-Endocrinology

    Zhenjiang, Jiangsu, China · Recruiting

  • Huzhou Central Hospital-Endocrinology

    Huzhou, Zhejiang, China · Recruiting

  • Regionshospitalet Gødstrup, Øre-næse-hals-kirurgisk

    Herning, Denmark · Recruiting

  • Sjællands Universitetshospital, Køge - Øre-Næse-Hals afdeling

    Køge, Denmark · Recruiting

  • Siteworks GmbH Bochum

    Bochum, Germany · Recruiting

  • Wendisch - Dahl Hamburg - DZHW

    Hamburg, Germany · Recruiting

  • Siteworks GmbH Hannover

    Hanover, Germany · Recruiting

  • Siteworks GmbH Karlsruhe

    Karlsruhe, Germany · Recruiting

  • Institut für Diabetesforschung GmbH Münster - Dr. med. Rose

    Münster, Germany · Recruiting

  • Siteworks GmbH - Prüfzentrum Schleswig | RespiRatio

    Schleswig, Germany · Recruiting

  • Asthma Bhawan

    Jaipur, India · Recruiting

  • Vardhaman Mahavir Medical College & Safdarjung Hospital

    New Delhi, India · Recruiting

  • Guntur Government medical College

    Guntur, Andhra Pradesh, India · Completed

  • Government Siddhartha Medical College & Government General Hospital, Vijayawada

    Vijayawada, Andhra Pradesh, India · Recruiting

  • Rajarajeswari Medical College and Hospital

    Bengaluru, Karnataka, India · Recruiting

Showing 40 of 80 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.